CENTER OF MOLECULAR IMMUNOLOGY(CIM).CIMAB
Trials shown by sponsor
Public title | Date of Registration | State |
---|---|---|
iorEPOCIM-Stroke-Phase I | 2012-09-17 | Registered outdated |
Safety evaluation of Recombinant Human Erythropoietin ior EPOCIM in the treatment of patient with cerebral infarction acute. Study Stage I. | 2009-07-03 | Registered outdated |
ior ®EPOCIM as a cardioprotective agent in the surgery of rheumatic valvular disease. | 26/08/2013 | Registered outdated |